These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9667274)

  • 1. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
    O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE
    J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
    Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D
    J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin.
    Lorenz M; Hottenrott C; Maier P; Reimann M; Inglis R; Encke A
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):163-70. PubMed ID: 1532672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.
    Stagg RJ; Venook AP; Chase JL; Lewis BJ; Warren RS; Roh M; Mulvihill SJ; Grobman BJ; Rayner AA; Hohn DC
    J Natl Cancer Inst; 1991 Mar; 83(6):423-8. PubMed ID: 1825674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
    Kemeny N; Seiter K; Niedzwiecki D; Chapman D; Sigurdson E; Cohen A; Botet J; Oderman P; Murray P
    Cancer; 1992 Jan; 69(2):327-34. PubMed ID: 1303612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver.
    Wagman LD; Kemeny MM; Leong L; Terz JJ; Hill LR; Beatty JD; Kokal WA; Riihimaki DU
    J Clin Oncol; 1990 Nov; 8(11):1885-93. PubMed ID: 2146370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC; Stagg RJ; Friedman MA; Hannigan JF; Rayner A; Ignoffo RJ; Acord P; Lewis BJ
    J Clin Oncol; 1989 Nov; 7(11):1646-54. PubMed ID: 2530317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
    Kemeny N; Cohen A; Bertino JR; Sigurdson ER; Botet J; Oderman P
    Cancer; 1990 Jun; 65(11):2446-50. PubMed ID: 2140070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
    J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of pulse 5-fluoro-2'-deoxyuridine and leucovorin in advanced colorectal cancer patients previously treated with chemotherapy.
    Marsh JC; Durivage HJ; Davis C; O'Hollaren K; Pasquale DN; Simonich SA; Voynick IM; Bertino JR
    Am J Clin Oncol; 1992 Apr; 15(2):115-8. PubMed ID: 1532470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and i.v. 5-fluorouracil (5-FU) chemotherapy for unresectable colorectal liver metastases: an alternative to FUdR-based regimens?
    Cosimelli M; Mannella E; Anzá M; Civalleri D; Balletto N; Di Tora P; Durante F; Porcellana M; Cavaliere P; Anfossi A
    J Surg Oncol Suppl; 1991; 2():63-8. PubMed ID: 1832541
    [No Abstract]   [Full Text] [Related]  

  • 14. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases.
    Barone RM; Byfield JE; Goldfarb PB; Frankel S; Ginn C; Greer S
    Cancer; 1982 Sep; 50(5):850-62. PubMed ID: 6212114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
    Kemeny N; Daly J; Reichman B; Geller N; Botet J; Oderman P
    Ann Intern Med; 1987 Oct; 107(4):459-65. PubMed ID: 2957943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of liver metastases from colorectal cancer with continuous high dose intra-arterial floxuridine (FUDR) and systemic fluorouracil: a phase II study.
    Planting AS; Runhaar EA; Verwey J; Taal BG; Blijham G; Neyt JP
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1887-8. PubMed ID: 2534382
    [No Abstract]   [Full Text] [Related]  

  • 17. Regional chemotherapy of colorectal cancer metastatic to the liver.
    Niederhuber JE; Ensminger W; Gyves J; Thrall J; Walker S; Cozzi E
    Cancer; 1984 Mar; 53(6):1336-43. PubMed ID: 6229326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy.
    Preketes AP; Caplehorn JR; King J; Clingan PR; Ross WB; Morris DL
    World J Surg; 1995; 19(5):768-71. PubMed ID: 7571679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.
    Kemeny NE; Jarnagin WR; Capanu M; Fong Y; Gewirtz AN; Dematteo RP; D'Angelica MI
    J Clin Oncol; 2011 Mar; 29(7):884-9. PubMed ID: 21189384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
    Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM
    Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.